Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydralazine in heart failure.

K Chatterjee

    Herz
    |August 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Hydralazine, a vasodilator, improves heart function by increasing cardiac output in heart failure patients. While it offers hemodynamic benefits, its long-term impact on overall prognosis in chronic heart failure remains uncertain.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Jet Shapes of Isolated Photon-Tagged Jets in Pb-Pb and pp Collisions at sqrt[s_{NN}]=5.02  TeV.

    Physical review letters·2019
    Same author

    Search for W Boson Decays to Three Charged Pions.

    Physical review letters·2019
    Same author

    Measurement of the top quark mass in the all-jets final state at <math> </math> and combination with the lepton+jets channel.

    The European physical journal. C, Particles and fields·2019
    Same author

    Observation of Single Top Quark Production in Association with a Z Boson in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2019
    Same author

    Observation of Two Excited B_{c}^{+} States and Measurement of the B_{c}^{+}(2S) Mass in pp Collisions at sqrt[s]=13  TeV.

    Physical review letters·2019
    Same author

    Search for Dark Matter Particles Produced in Association with a Top Quark Pair at sqrt[s]=13  TeV.

    Physical review letters·2019
    Same journal

    [Heart and climate].

    Herz·2026
    Same journal

    Multidimensional psychosocial screening in routine cardiac care: preliminary findings from a cross-sectional survey.

    Herz·2026
    Same journal

    [Noise and the heart].

    Herz·2026
    Same journal

    [The cardiovascular exposome: areas of action for prevention and practical cardiology].

    Herz·2026
    Same journal

    Relationship between HAVOC score and new-onset atrial fibrillation in patients with ST elevation myocardial infarction.

    Herz·2026
    Same journal

    Interventional treatment of atrioventricular valves.

    Herz·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Hydralazine is a vasodilator that relaxes smooth muscle.
    • It is used to treat heart failure and valvular regurgitation.

    Purpose of the Study:

    • To evaluate the hemodynamic and clinical effects of hydralazine in heart failure patients.
    • To assess the long-term role and prognosis of hydralazine therapy.

    Main Methods:

    • Review of hemodynamic effects in patients with heart failure.
    • Analysis of clinical outcomes in patients receiving hydralazine therapy.

    Main Results:

    • Hydralazine increases cardiac output and stroke volume, decreasing vascular resistance.
    • Beneficial hemodynamic effects are observed in mitral/aortic regurgitation and ventricular septal defects.

    Related Experiment Videos

  • Sustained hemodynamic and clinical benefits are seen in chronic low-output heart failure.
  • Long-term prognosis in chronic heart failure remains unchanged overall.

    • Conclusions:

    • Hydralazine provides significant hemodynamic improvements in various heart conditions.
    • The long-term prognostic value of hydralazine in chronic heart failure requires further investigation.
    • Certain patient subsets may experience better prognoses with long-term hydralazine therapy.